Akari Therapeutics Plc (AKTX)

0.2672 +0.02 (+8.93%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Akari Therapeutics Cash and Short Term Investments (Annual): 2.659M for Dec. 31, 2024

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
DBV Technologies SA 32.46M
Cellectis SA 260.31M
Biodexa Pharmaceuticals Plc 2.090M
NuCana Plc 8.452M
Autolus Therapeutics Plc 589.45M